Figure 5

Effect of COX-2 silencing mediated by InvColi-pS on CRC cell proliferation and viability. Cell number and cell viability were evaluated in (A, B) infected HT-29 and (C, D) HCA-7 cells, respectively. (♦): cells infected with InvColi-pS⁻; (▪): cells infected with InvColi-pS^H1; (▴): cells infected with InvColi-pS^COX−2; (•): cells infected with InvColi-pS^TBE. Viability was evaluated using the Trypan Blue exclusion assay and quantified as ((number of unstained cells)/(number of total cells)) × 100. Data represent mean±s.e.m. of three independent experiments. ^*P<0.01.